These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26704150)

  • 21. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study.
    Happe S; Berger K;
    J Neurol; 2001 Dec; 248(12):1062-7. PubMed ID: 12013583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenomenology of dreams in Parkinson's disease.
    Borek LL; Kohn R; Friedman JH
    Mov Disord; 2007 Jan; 22(2):198-202. PubMed ID: 17133561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociated resting-state functional networks between the dream recall frequency and REM sleep percentage.
    Zou Q; Zhou S; Xu J; Su Z; Li Y; Ma Y; Sun H; Wu CW; Gao JH
    Neuroimage; 2018 Jul; 174():248-256. PubMed ID: 29544817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis.
    Lenka A; Ingalhalikar M; Shah A; Saini J; Arumugham SS; Hegde S; George L; Reddy V; Reddy YCJ; Yadav R; Pal PK
    J Neural Transm (Vienna); 2018 Sep; 125(9):1361-1372. PubMed ID: 29858658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
    Shepherd TA; Edelstyn NM; Mayes AR; Ellis SJ
    J Neuropsychol; 2013 Sep; 7(2):284-305. PubMed ID: 23815454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dream recall after sleep interruption in brain-injured patients.
    Murri L; Massetani R; Siciliano G; Giovanditti L; Arena R
    Sleep; 1985 Dec; 8(4):356-62. PubMed ID: 3880176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the neuropsychology of dreaming: Insights into the neural basis of dreaming with new techniques of sleep recording and analysis.
    Cipolli C; Ferrara M; De Gennaro L; Plazzi G
    Sleep Med Rev; 2017 Oct; 35():8-20. PubMed ID: 27569701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dream Recall Frequencies and Dream Content in Wilson's Disease with and without REM Sleep Behaviour Disorder: A Neurooneirologic Study.
    Tribl GG; Trindade MC; Schredl M; Pires J; Reinhard I; Bittencourt T; Lorenzi-Filho G; Alves RC; de Andrade DC; Fonoff ET; Bor-Seng-Shu E; Machado AA; Teixeira MJ; Barbosa ER
    Behav Neurol; 2016; 2016():2983205. PubMed ID: 27051076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic exposure to dopamine agonists affects the integrity of striatal D
    Politis M; Wilson H; Wu K; Brooks DJ; Piccini P
    Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daydreams and nap dreams: Content comparisons.
    Carr M; Nielsen T
    Conscious Cogn; 2015 Nov; 36():196-205. PubMed ID: 26164253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
    Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
    J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dream features in the early stages of Parkinson's disease.
    Bugalho P; Paiva T
    J Neural Transm (Vienna); 2011 Nov; 118(11):1613-9. PubMed ID: 21717220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine agonists and sleep in Parkinson's disease.
    Cantor CR; Stern MB
    Neurology; 2002 Feb; 58(4 Suppl 1):S71-8. PubMed ID: 11909988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease.
    Metman LV; Gillespie M; Farmer C; Bibbiani F; Konitsiotis S; Morris M; Shill H; Bara-Jimenez W; Mouradian MM; Chase TN
    Clin Neuropharmacol; 2001; 24(3):163-9. PubMed ID: 11391128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of varenicline in smokeless tobacco cessation influences sleep quality and dream recall frequency but not dream affect.
    Polini F; Principe R; Scarpelli S; Clementi F; De Gennaro L
    Sleep Med; 2017 Feb; 30():1-6. PubMed ID: 28215231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recalling and forgetting dreams: theta and alpha oscillations during sleep predict subsequent dream recall.
    Marzano C; Ferrara M; Mauro F; Moroni F; Gorgoni M; Tempesta D; Cipolli C; De Gennaro L
    J Neurosci; 2011 May; 31(18):6674-83. PubMed ID: 21543596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weak electromagnetic fields restore dream recall in patients with multiple sclerosis.
    Sandyk R
    Int J Neurosci; 1995 May; 82(1-2):113-25. PubMed ID: 7591509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
    Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
    Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic gambling in patients with Parkinson's disease.
    Gschwandtner U; Aston J; Renaud S; Fuhr P
    Clin Neuropharmacol; 2001; 24(3):170-2. PubMed ID: 11391129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.